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SUMMARY 
A study was conducted to compare the efficacy of meditation with that of imipramine and chlordiazepoxide in the 
treatment of Generalized Anxiety Disorder. At the end of five weeks, meditation was found to be as effective as 
pharmacotherapy in controlling symptoms of anxiety. It was superior in altering trait anxiety (TMAS Scores). 
Meditation is an easy to learn and cost effective therapy. It has a distinct edge over pharmacotherapy in that it is 
does not have the associated problems of habit formation,-withdrawal effects, overdosage or other undesirable 
effects. 
INTRODUCTION 
Ever since the first century A.D., clinicians have noted 
the significance of anxiety in psychiatricdisorders(Spitzer 
& Williams, 1984). The clinical approach to anxiety varies 
with the orientation of the therapist. Contemporary 
schools of psychology offer different hypotheses to ex-
plain the psychodynamics of anxiety genesis, and the 
therapeutic techniques used varies with the theoretical 
construct. Behavior therapists advocate desensitizing a 
person to anxiety provoking stimuli. Cognitive therapists 
attempt to modify cognition of the anxiety provoking 
event. Existentialists highlight non-defensive therapeutic 
encounter. Psychoanalysts endeavor to bring about con-
scious awareness of unconscious motives. (Frank, 1984). 
It is interesting to note that all the schools of psychology 
take cognisance of the factors that generate anxiety. They 
attempt to deal either with the emotional response to or the 
subjective perception of a stressful event, or with 
symptoms of anxiety. 
Wright's model, (1988) (with some modifications) 
incorporates the contemporary schools of psychology into 
a theoretical construct of anxiety. 
Stage l:Biopsychosocial stimulus (Frank 1984) 
Stage 2: Appraisal/Subjective Interpretation of the 
stimulus 
Stage 3:Emotional response to the appraisal/inter-
pretation (perceived dangerAhreat/demoraliz-
ing effect) 
Stage 4:Behavioral inclination 
Stage 5:Maladaptive Behavior/Anxiety 
Psychotherapy, behavior therapy and cognitive 
therapy deal with anxiety by effecting a change at Stage 3 
of this model. A stimulus response model dominates the 
clinical appraisal. Emphasis on "internal determinism" as 
opposed to the conventional concept of "external deter-
minism" is considered by cognitive therapists to be a 
specific feature of their clinical approach. (Shaw & Segal, 
1988). Relaxation therapy and pharmacotherapy attempt 
to alleviate symptoms of anxiety; they modify Stage 5 of 
the cycle. Patanjali, an Indian Philosopher (Vivekananda, 
1966) advocates the practice of meditation to combat 
anxiety. His concept differs in its basic presumptions from 
other schools of psychology; it attempts intervention at 
Stages 2 and 4 of the model. According to Patanjali, an 
individual's thoughts and behavior tend to depend on 
environmental feedback. Every action of an individual 
results in a feedback from the environment. Positive feed-
back is reassuring, while negative feedback induces a 
subjective feeling of inadequacy and anxiety. Anxiety 
reduces the attention span and increases distractibility; 
such a state adversely affects personal and occupational 
efficiency, thus reinforcing the negative feedback and a 
subjective feeling of unpleasantness is then generated. 
This would, in turn, aggravate psychological and 
physiological symptoms of anxiety. This feeling leads to 
furtherdeterioration in efficiency, causinggreateranxiety. 
The cycle then self-perpetuates. (Frank, 1984; Vivekanan-
da, 1966). Thus, preoccupation with environmental feed-
back contributes to psychological and physiological 
symptoms of anxiety. This view is generally accepted in 
contemporary psychiatry (Frank, 1984; Shaw & Segal, 
1988; Wright, 1988). 
In this pattern of stimulus response behavior, repercus-
sions of behavior become the determinants of a personal 
sense of well being (Vivekananda, 1966). Patanjali, in his 
concept, advocates a change in the orientation towards the 
environment and suggests that environment should be 
viewed as an opportunity for the utilization of one's 
abilities and not as a measure or a determinant of a sense 
of well being and adequacy. It should be delinked from 
stimulus response behavior and its repercussions, and the 
practice of meditation enables the individual to achieve 
this (Vivekananda, 1966). 
Meditation is defined as ".. a family of techniques, 
which have in common a conscious attempt to focus 
attention in a non-analytical way, and attempt not to dwell 
on discursive ruminating thought" (Shapiro, 1984). The 
process of therapeutic efficacy of meditation can be 
diagrammatically explained as follows: 
Disease Process 
Biopsychosodal Stimulus 
Decreased feeling • Uncontrolled discursive 
of well being thoughts . 
Negative environments! Psychological and physical 
feedback symptoms of Anxiety 
Reduction in functioning capacity 4— Reduced concentratioa 
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and physical symptoms 
A reeling of we! being *-
Biopsycrxisocial stimulus 
Mediation 
Decrease in dacuniva 
thoughts*! isiractibiity 
Improvement in 
concentration during therapy 
Improvement In 
concentration at work 
Increased efficiency 
The practice of meditation combats anxiety by reduc-
ing distractibility; reduced distractibility and improved 
concentration enhance personal and occupational efficien-
cy, which in turn induces a positive self image resulting in 
a reduction in the level of anxiety. Improvement is thus 
brought about by optimal utilization of one's abilities in 
the chosen field of activity and reduced preoccupation 
with environmental influences. 
The study of meditation in psychiatric illness is an area 
of active interest amongst researchers. Literature regard-
ing its usefulness, potential dangers and limitations has 
been previously published (Vahia et al, 1973). This study 
aims at investigating the efficacy of meditation in com-
parison to currently accepted pharmacotherapy in the 
management of General ized Anxiety Disorder. 
AIMS OF THE STUDY 
1. To determine whether the practice of meditation is 
effective in the management of anxious patients seek-
ing medical help. 
2. To compare the efficacy of meditation and phar-
macotherapy i n decreasing symptoms and reducing the 
predisposition to anxiety. 
MATERIAL AND METHOD 
The study was conducted in the psychiatry out patient 
department of a teaching general hospital in Bombay. 
a. Inclusion Criteria 
1. DSM-III (American Psychiatric As-
sociation, 1980) diagnosis of 
Generalized Anxiety Disorder, in-
dependently confirmed by two 
psychiatrists. 
2. Age Group 18-45 years. 
b. Exclusion Cri teria 
1. Concomitant physical illness 
2. Substance Use Disorder 
3. Mental Subnormality 
Untreated patients who approached the psychiatric 
OPD and fulfilled the criteria were included in this study. 
They were randomly distributed to Index and Control 
groups. The Index group was treated with meditation and 
a placebo (glucose powder in opaque capsules). The Con-
trol group received individualized dose of imipramine 75 
to 225 mg and Chlordiazepoxide 10 to 40 mg per day in 
opaque capsules (Kahn et al, 1986) and pseudomeditation. 
The dose of medication was adjusted by a therapist (HKS) 
who was open to the study. All patients received one 
capsule thrice a day. 
Individual meditation/ pseudomeditation sessions 
were conducted for 30 minutes for each patient. Medita-
tion/ pseudomeditation was practiced as follows: 
Meditation (Index Group) 
The aim of therapy was to learn to focus attention on 
chosen imagery and to learn not to dwell upon discursive 
thoughts. Patients were helped to select an appealing, 
everlasting and unchanging mental image. They were 
asked to assume a comfortable, supine posture and con-
centrate on the chosen imagery, while regulating breath-
ing. They were informed that concentration would be 
interrupted by various thoughts and that a voluntary effort 
would have to be made to exclude these discursive 
thoughts and to focus attention on the chosen imagery; 
with practice, the ability to discard discursive thoughts arid 
retain concentration on the chosen imagery would im-
prove. Over a period of time, this ability of focussing on 
the chosen task, free of discursive thoughts, would be 
noticed in their daily life situation. Such a state would 
enable them to function effectively with reduced vul-
nerability to environmental feedback. 
Pseudomeditation (Control Group) 
This group was reassured that with therapeutic sessions 
and drugs, there would be a gradual improvement. They 
were advised to lie down on a couch in a relaxed state and 
regularize breathing during the sessions. 
All patients in both the groups had six sessions per 
week, each lasting 30 minutes for five weeks, ie., a total 
of 30 sessions. All sessions were supervised. At the end of 
each session, patients in both groups were asked to record 
the frequency and details of their discursive thoughts. 
Assessment: 
All cases were assessed on the following measures: 
1. Hamil ton Anxiety Rati ng Scale 
(HARS), (Hamilton, 1959) 
2. Taylor's Manifest Anxiety Scale all cases. 
(TMAS), (Taylor 1953) 
3. Subjective records of discursive 
thoughts of cases in the Index 
Group were analyzed for numerical 
frequency of the discursive 
thoughts experienced during the 
therapeutic session.50% or more 
reduction in frequency of the dis-
cursive thoughts at the end of 30 
sessions was considered to be an in-
dicator of effective meditation). 
HARS (by a rater blind to the treatment modality) and 
TMAS were rated pretreatment, at the end of 15 and 30 
sessions. 
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Analysis of Data: 
This paper presents a part of an ongoing study. Data 
from 67 cases are presented here. Of the 67 cases, 23 
belonged to the Index (I) Group, 23 belonged to the 
Control (C) Group, and 21 cases formed a Drop Out (D) 
• Group. The (D) Group Cases had dropped out of the study 
within a week of pretreatment evaluation. However, they 
continued to be followed up in the psychiatry out patient 
department. Their HARS and TMAS were rated pretreat-
ment and at the end of five weeks. 
Analysis of records of discursive thoughts of the (I) 
Group revealed that of the 23 patients in the meditation 
group, 16 patients had a 50% or more reduction in the 
numerical frequency of discursive thoughts. This group of 
effective meditators was designated Ii. Seven cases from 
the Index Group had less than 50% reduction in the 
numerical frequency of discursive thoughts. This group 
which could not meditate effectively was designated the 
h group. Division of the I group into Ii and 12 was not 
predesigned. 
Thus, the 67 patients fell into the following four 
groups: 
Ii (n = 16): Patients who could meditate effectively 
+ placebo. 
b(n= 7) : Patients who could not meditate effec-
tively +placebo. 
C (n = 23) Patients on pharmacotherapy + pseudo-
meditation. 
D (n = 21) Patients on pharmacotherapy only. 
Comparing Ii group with the 12, C & D groups would 
elicit the differences, if any, in the efficacy of meditation, 
placebo and pharmacotherapy. 
The pretreatment scores of HARS & TMAS and scores 
at the end of 30 sessions / 5 weeks were analyzed using 
the following tests. 
1. "t" test (Garret, 1971). 
2. Analysis of Covariance with Independent Vari-
ables and Covariates (ANOVA) (Norusis, 1986). 
RESULTS 
Pre-treatment analysis of variance: 
Analysis of variance was undertaken to determine im-
pact of age, gender, religion, per capita income and dura-
tion of illness on the pretreatment HARS & TMAS scores. 
These variables did not have any impact on the scores. 
HARS: F=0.605, p=0.615 NS; TMAS: F=0.399, p=0.754 
NS; Hence, h, I2, C, D groups were comparable for 
covariates. 
HARS Scores: Improvement in State Anxiety 
Anal ysis of difference between pre-treatment and post-
treatment HARS Scores within the four groups revealed 
that patients who could meditate effectively (50% or more 
reduction in frequency of discursive thoughts) and those 
who received anxiolytic pharmacotherapy (imipramine + 
chlordiazepoxide) responded to treatment; Group Ii: 
t=3.97,df=15,p=0.001; GroupC: t=4.07, df=22, p=0.001; 
Group D: t=3.25, df=20, p=0.004 (Chart I), the I2 group 
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which could neither meditate effectively nor receive 
anxiolytic medication, did not show any significant 
change in its HARS scores (t=1.00, df=6, p=0.356). Com-
parison of the mean improvement between the four groups 
confirmed the observation that meditation is as effective 
as pharmacotherapy in controlling state anxiety. The C 
group had received pharmacotherapy and pseudomedita-
tion, while Group D had received only pharmacotherapy 
identical to that of Group C. The improvement between C 
group and D group is comparable: Hence, it is inferred that 
pseudomeditation had no impact on treatment efficacy. 
TMAS Scores - Improvement in Trait Anxiety 
(Spielberger, 1966) 
Trait anxiety ie., the tendency of responding in an 
anxious manner to stressful stimuli (Thomas & Abbas, 










1978) was studied by comparing pre and post-treatment 
TMAS scores (Chart II). It was noticed that the Ii group 
had a statistically significant reduction in the TMAS 
scores after treatment (t=2.31, df=15, p=0.036). The 
reduction in the C and D groups was not statistically 
significant (Group C: t=0.1, df=18.0, p=0.9; Group D: 
t=1.54, df=19.0, p=0.139). This suggests that meditation 
alters the pattern of responding to biopsychosocial events 
89 (Frank 1984). It is thus inferred that only those who 
meditated were able to leam to respond to biopsychosocial. 
stimuli without experiencing anxiety. Here again, pseudo-
meditation did not contribute to the improvement. 
DISCUSSION 
Therapeutic goals for intervention in Generalized 
Anxiety Disorders are symptom alleviation and long term 
management, to prevent the re-emergence of symptoms. 
With reference to Wright's model (1988), meditation 
achieves both the goals in a manner which is unique for 
this therapeutic strategy. Our sample exhibited the allevia-
tion of symptoms with meditation which was comparable 
to the symptom relief produced by pharmacotherapy. 
Apart from symptom alleviation, trait anxiety (TMAS 
scores) showed a superior response to meditation at the 
end of 30 sessions. The authors contend that this is a 
specific feature of meditation as a treatment modality. It 
alters the basic response pattern, thereby preventing the 
genesisofanxiety. Meditation isaisodevoid of theadverse 
effects of pharmacotherapy (American Psychiatric As-
sociation, 1990; Priest, 1989; Vahia et al, 1988). 
The emergence of a group of 7 patients, designated as 
the h group, formed an i nteresting aspect of the study. This 
group was not under experimental control. During the 
course of the treatment, this group was designated and 
treated as a part of the index group. The 7 patient in 12 
group did not differ in their pre-treatment HARS and 
TMAS scores from the rest of the sample. At the end of 
30 sessions, their TMAS scores had deteriorated. 
The 12 group in effect, did not receive any specific 
therapeutic intervention. Cases in this group were given a 
placebo and were expected to practice meditation. How-
ever, they were not able to meditate effectively and their 
disease process continued unabated. In this sense, h be-
came the true "double blind" group of the study. The 
reason behind this group's difficulty in practicing medita-
tion is currently being studied. 
The improvement observed i n our sample could be due 
to the contribution of covariates, the effect of the 
therapeutic milieu, or due to the primary and specific 
therapeutic effect of the treatment (meditation, pseudo-
meditation or pharmacotherapy). 
The pretreatment ANOV A confirmed that there was no 
sample bias, and the study was double blind. The milieu 
was thus identical for the four groups. Hence, the observed 
improvement could be attributed to either a drug effect or 
pseudomeditation or to the specific effects of meditation. 
The effect of pseudomeditation would reflect in the im-
provement in group C as compared to group D. The results 
show that both these groups had identical improvement as 
gauged by HARS & TAMS; Hence, pseudomeditation did 
not offer any specific advantage. The efficacy of phar-
macotherapy in generalized anxiety disorder is well estab-
lished (Kahn, 1986). Our results so far indicate that 
meditation by itself is effective in the management of 
Generalized Anxiety Disorder. 
Literature describes several methods of practice of 
meditation (Corby et al, 1978; Fischer, 1971; Thomas & 
Abbas, 1978; Walrath & Hamilton, 1978). In this study, 
Patanjali's method of meditation was selected as it is (i) 
Simple to conceptualize (ii) Easy to practice and (iii) Free 
of cultural and religious bias. 
The first 30 sessions of meditation were supervised; at 
the end of this, the patients in Group Ii were interviewed 
to determine their confidence in practicing meditation 
without continuous supervision. They were asked to report 
if their confidence in practicing meditation independently 
was fel t to be unsatisfactory; they were also asked to report 
every month for assessment. None of the 16 patients 
reported difficulties in practicing meditation inde-
pendently, and we hope to be able to furnish the experience 
of this group and other data from the currently ongoing 
study in due course of time. 
Adverse Effects 
In the course of our study, no adverse effects were 
manifest. However, Carrington (1978) cautions against 
advocating meditation for borderline states. Feeling of 
dissociation and dizziness are reported to be adverse ef-
fects of meditation. Efficacy of meditation in patients with 
depression and migraine is controversial (Carrington, 
1978; Vahia, 1973). 
CONCLUSIONS 
i. Meditation is effective in the management of General-
ized Anxiety Disorder. 
ii. Meditation and Imipramine + Chlordiazepoxide are 
equally effective. Meditation is superior to medication 
as it is devoid of untoward effect of pharmacotherapy. 
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